November 30, 2017 / 9:41 PM / 16 days ago

BRIEF-FDA Announces Approval, CMS Proposes Coverage Of First Breakthrough-Designated Test To Detect Extensive Number Of Cancer Biomarkers

Nov 30 (Reuters) - U.S. Food and Drug Administration:

* FDA ANNOUNCES APPROVAL, CMS PROPOSES COVERAGE OF FIRST BREAKTHROUGH-DESIGNATED TEST TO DETECT EXTENSIVE NUMBER OF CANCER BIOMARKERS

* FDA SAYS GRANTED APPROVAL FOR THE F1CDX TEST TO FOUNDATION MEDICINE INC

* U.S. FDA SAYS APPROVED FOUNDATIONONE CDX IN-VITRO DIAGNOSTIC TEST Further company coverage: [U.S. FDA]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below